Search Results for 'Immunology'

77 results found.

Blood type diet

Have you ever wondered why some people are able to lose weight on a particular diet and others are not? Why some people are plagued by poor health or deterioration due to ageing, while others seem to live healthy, vital lives?

Doctor warns people with peanut allergies to be vigilant

image preview

People with peanut allergies are being urged to be extra vigilant when eating out following two recent deaths from food allergy in the UK. One involved a 21-year-old footballer who died after suffering a severe allergic reaction to a curry containing peanuts.

Good news for Elan as study illustrates Tysabri MS success

image preview

Athlone-based drug developer and its US partner, Biogen Idec, last evening hailed success from a study into the effects of their MS drug, Tysabri in repairing damage to the myelin sheath, a key cause of MS.

Hayfever management

The summer months are fast approaching and for many thousands of people this signals the return of hayfever season. Hayfever, also known as seasonal allergic rhinitis, is a common condition that affects approximately one in five people and arises from an allergy to airborne substances such as grass or hay pollen.

Treatment with Chinese herbal medicines and acupuncture

Every year it’s the same thing; many people seek help for itchy eyes and runny noses, symptoms varying in degree from sneezing to allergic asthma.

Allergy free living

Very often, when you have people living in your home with allergies there are several restrictions that can arise when it comes to your home interior. You will have to take extra care about the materials you use when you decorating your home. However, just because allergies exist in the home there is no reason for it to look barren and cold. You can still decorate your home to be attractive and inviting. Here are some tips that you can use when decorating an allergy free home.

Elan’s Tysabri lowers Crohn’s hospitalisations

Athlone-based pharmaceutical company, Elan, and its US partner Biogen have announced that their drug Tysabri has been proven to significantly reduce the rate of hospitalisation of patients with moderate-to-severe Crohn’s disease.

 

Page generated in 0.0642 seconds.